SynthesisAJNR. American journal of neuroradiology2025
Nontrauma-Associated Cerebral Fat Embolism Syndrome in Sickle Cell-Related Hemoglobinopathies: A Case Series and Systematic Review.
Synthesis in AJNR. American journal of neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCerebral fat embolism (CFE) is frequently associated with long bone fractures and orthopedic procedures but can rarely occur without antecedent trauma. Nontrauma-associated CFE has been reported in patients with sickle cell-related hemoglobinopathies during sickle cell crises, presumably due to bone marrow infarction. PURPOSE: To characterize the brain MRI features of nontrauma-associated CFE in patients with sickle cell-related hemoglobinopathies during the acute, subacute, and chronic phases after the onset of neurologic symptoms. DATA SOURCE: This was a combined case series and systematic review of MEDLINE, EMBASE, and Google Scholar databases up to April 2023. This systematic review was not registered with a review registry. STUDY SELECTION: Patients with sickle cell-related hemoglobinopathies who developed nontrauma-associated CFE were selected based on clinicopathologic evidence and brain MRI findings. DATA ANALYSIS: Clinical and radiologic data were reviewed. DATA SYNTHESIS: The systematic review included 26 studies and our 6 unpublished cases, totaling 33 cases of sickle cell-related hemoglobinopathies presenting with nontrauma-associated CFE (91 MRI examinations). Among the patients reviewed, the predominant hemoglobinopathy associated with nontrauma-associated CFE was hemoglobin SC disease (Hb-SC, 61.3%), followed by hemoglobin S/beta-thalassemia (22.6%), and homozygous sickle cell disease (Hb-SS 12.9%). Head CT scans were normal in 77% of the patients. The most frequently observed MRI feature during the acute phase was punctate foci of microhemorrhage (84.7% of cases), which persisted throughout the subacute (91%) and chronic phases (85.8%). The second most common MRI finding during the acute phase was scattered foci of restricted diffusion in a "starfield pattern" affecting both cerebral and cerebellar hemispheres (65.4% of cases), which typically was not observable after 5 days. LIMITATIONS: The review was based on case reports and small case series, which are subject to reporting bias.
conclusionsBrain imaging features of nontrauma-associated CFE in the setting of sickle cell-related hemoglobinopathies closely resembled those observed in trauma-related CFE. In patients with complex sickle cell-related hemoglobinopathies (Hb-SC and Hb-S/beta-thalassemia) exhibiting unexplained acute neurologic symptoms, radiologists should maintain a high index of suspicion for nontrauma-associated CFE, even with apparently normal initial head CT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.